Investors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company’s overall profitability. Covering equity analysts are expecting Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) to post quarterly EPS of $-0.08.
The earnings report has the ability to trigger near-term movements of the stock whether results hit or miss expectations. Before the earnings report, investors might be watching directional trends of estimates. The company posted actual EPS for the last quarter of $-0.11. The Zacks Research consensus estimate prior to earnings was $-0.05. The difference between the two numbers was $-0.06 which resulted in a surprise factor of -120%.
3 analysts polled by Zacks Research currently have a mean target price of $7.083 on Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP). The top target is presently $8 and the lowest target has the stock reaching $6.25 within the year. In looking at the standard deviation of all estimates, we arrive at 0.877. Zacks Research also uses an analyst ratings scale that spans from 1 to 5. Using this scale, a 1 would indicate a Strong Buy, and a 5 rating would represent a Strong Sell rating. Using all the ratings on Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), the mean rests at 1. Breaking those down we see that the ratings are as follows: 3 Strong Buy, 0 Rated Buy, 0 Rated Hold and 0 Rated Sell.
Analyst recommendations and estimates are for informational purposes only and should be used along with a number of other factors when considering an investment position. Part of the data in this report is derived from Zacks Research and FactSet. Ratings and estimates change daily and thus the numbers may differ slightly if a new report has been issued within the last 24-hours. The consensus numbers take into account the reports from over 160 brokerage firms. The job of analysts is to issue recommendations for their clients, and not typically for the general public. Analyst forecasts, earnings estimates and price target projections are issued to help their clients make money through stock investments. We in no way are suggesting that readers make any decision based on the information in this report.